tumors that shows limited response to standard therapies. Clinicopathologic parameters or biomarkers to stratify this neoplasia are lacking. Our group recently reported a molecular analysis on 62 uRCCs (discovery cohorte [DC]) and identified distinct molecular subsets. We aim to validate this molecular stratification in an independent clinical cohort and further investigate molecular features that could help refine prognostication and guide management.
INTRODUCTION AND OBJECTIVES: Sarcopenia (low skeletal muscle mass) is independently associated with poor outcomes among patients with clear cell renal cell carcinoma (ccRCC). We examined gene expression differences among sarcopenic and non-sarcopenic patients to identify pathways that may explain this association.
METHODS: 62 ccRCC patients treated by nephrectomy at Memorial Sloan Kettering Cancer Center were transcriptomicallyprofiled in The Cancer Genome Atlas. Computed tomography scans without contrast performed within 2 months of surgery were reviewed to determine skeletal muscle cross-sectional area. Sarcopenia (yes/ no) was defined according to gender-specific international consensus definitions (skeletal muscle index of < 55 cm2/m2 for men and < 39 cm2/m2 for women). Baseline differences in clinicopathologic features were assessed using the Chi-squared test for categorical and t-test for continuous variables. Differential expression analyses were performed using the R package 00 DESeq2 00 (version 1.16.1). Gene set enrichment analyses (GSEA) were used to evaluate differences in Molecular Signatures Database hallmark gene sets (v6.0). Immune deconvolution using single-sample GSEA was utilized with previously published immune cell signatures (Bindea, et al.) to estimate immune cell infiltration. P-values were corrected for multiple testing (P-adjust) using the Benjamini-Hochberg method.
RESULTS: The cohort was predominantly male (82%) and white (97%) and had localized disease (58%). Median age was 58.9 years (SD: 12.1). Overall, 47% were sarcopenic and these patients tended to be older (P<0.001), to be obese (P<0.001), and to present with higher AJCC stage (P[0.006). In primary tumor specimens, sarcopenic patients demonstrated increased expression of angiogenic, inflammatory (eg, IL-6, TNF-alpha), and epithelial mesenchymal transition programs (Padjust<0.05). Furthermore, sarcopenic patients had higher macrophage (P[0.003) and Th17 immune cell infiltration (P[0.003).
CONCLUSIONS: Our findings suggest that sarcopenic ccRCC patients harbor gene expression programs associated with more aggressive biology. Preliminary immune deconvolution analyses suggest that these patients have increased macrophage infiltration and decreased Th17 immune cell infiltration, both of which have been associated with worse prognosis in ccRCC. It is not clear whether sarcopenia is a cause or consequence of tumor aggressiveness. Validation of these results in a larger cohort of patients and orthogonal validation of immune deconvolution results using immunofluorescence is necessary.
Source of Funding: Ruth L. Kirschstein Research Service Award T32CA082088 (AS).

MP16-20 MULTI-PHOTON MICROSCOPY FOR CHARACTERIZATION OF RENAL CELL CARCINOMA PSEUDOCAPSULE: IMPLICATIONS FOR TUMOUR ENUCLEATION
Yi Quan Tan, Wy Keat Tay*, Li Yin Ooi, Zui Chih Rachel Teo, Ho Yee Tiong, Singapore, Singapore INTRODUCTION AND OBJECTIVES: Tumor enucleation for Renal Cell Carcinoma (RCC) along its Pseudocapsule (PC) remains debatable with regards to oncological safety. Multiphoton Microscopy (MPM) combines Second Harmonic Generation (SHG) and Two Photon Excitation Fluorescence (TPEF) to image extracellular matrix architecture. In this study, MPM was used to characterize PCs at the tumourparenchymal interface to assess intratumoral variation.
METHODS: A commercially available laser-based MPM system (Histoindex, Singapore) was used, having the capability to detect and quantify fine collagen dynamics, unobserved with traditional staining techniques. From an Institutional Review Board-approved tissue repository, 20 tissue blocks were retrieved, cut into 4-micron sections, mounted on slides and deparaffinized. The PCs were imaged on 20X objective at selected Regions of Interest (ROIs). Corresponding clinical information from our partial nephrectomy database was retrieved. PC thickness was determined. Collagen was quantified by Collagen Area Ratio (CAR), while qualitative collagen parameters measured were Collagen Fiber Density (CFD) and Collagen Reticulation Index (CRI).
RESULTS: 20 pT1 RCC specimens (11 clear cell, 6 papillary, 3 chromophobe) were imaged. 15 patients were male, and mean age was
